Anti-inflammatory activity of nanogel formulation of 3-acetyl-11-keto- β-boswellic acid

Pharmacologyonline

Volumn 3, Issue , 2009, Pages 311-318

  Goel, Amit ^a   Ahmad, F J ^b   Singh, R M ^a   Singh, G N ^a  

^a Central Indian Pharmacopoeia Laboratory   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

3 acetyl 11 keto boswellic acid; Anti inflammatory; Carrageenan; Nanogel

Indexed keywords

3 ACETYL 11 KETO BETA BOSWELLIC ACID; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; BOSWELLIA SERRATA EXTRACT; CARBOMER; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BOSWELLIA; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG STRUCTURE; GEL; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PAW EDEMA; RAT; TOXICITY TESTING; TREATMENT OUTCOME; TREATMENT RESPONSE; VISCOSITY;

EID: 75449111159     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kulkarni RR, Patki PS, Jog VP, Gandage SG, Patwardhan B. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J. Ethnopharmacol. 1991; 33: 91-95.
2. Yu S, Ho CT, Chin CK, Badmaev V, Ma W, Huang MT. Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture. Planta Med. 1998; 64: 328-331.
3. Liu JJ, Huang B, Hooi SC. Acetyl-keto-beta-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells. Br. J. Pharmacol. 2006; 148: 1099-1107.
4. Huang MT, Badmaev V, Ding Y, Liu Y, Xie JG, Ho CT. Anti-tumor and anti-carcinogenic activities of triterpenoids, beta-boswellic acid. Biofactors 2000; 13: 225-230.
5. Bishnoi M, Patil CS, Kumar A, Kulkarni SK. Analgesic activity of acetyl-11-keto-β-boswellic acid, a 5-lipoxygenase enzyme inhibitor. Indian J. Pharmacol. 2005; 37: 255-256.
6. Menon MK, Kar A. Analgesic and psychopharmacological effects of the gum resin of Boswellia serrata. Planta Med. 1971; 19: 333-341.
7. Sailer ER, Subramanian LR, Rall B, Hoernlein RF, Ammon HPT, Safayhi H. Acetyl-11-keto- β-boswellic acid (AKBA):structrure requirements for binding and 5-lipoxygenase inhibitory activity. Br. J. Pharmacol. 1996; 117: 615-618.
8. Gupta I, Gupta V, Parihar A, Gupta SL, Udtke R, Safayhi H, Ammon HPT. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur. J. Med. Res. 1998; 3: 511-514.
9. Ammon HP. Boswellic acids in chronic inflammatory diseases. Planta Med. 2006; 72: 1100-1116.
10. Dahmen U, Gu YL, Dirsch O, Fan LM, Li J, Shen K, Broelsch CE. Boswellic acid, a potent anti-inflammatory drug, inhibits rejection to the same extent as high dose steroids. Transplant Proc. 2001; 33: 539-541.
11. Sharma ML, Bani S, Singh GB. Antiarthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis. Int. J. Immunopharmacol. 1989; 11: 647-652.
12. Singh S, Khajuria A, Taneja SC, Khajuria RK, Singh J, Qazi GN. Boswellic acids and glucosamine show synergistic effect in preclinical anti-inflammatory study in rats. Bioorg. Med. Chem. Lett. 2007; 17: 3706-3711.
13. Gupta OP, Sharma N, Chand D. Application of papaya latex-induced rat paw inflammation: model for evaluation of slowly acting antiarthritic drugs. J. Pharmacol. Toxicol. Methods 1994; 31: 95-98.
14. Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee-a randomized double blind placebo controlled trial. Phytomedicine 2003; 10: 3-7.
15. Gupta I, Parihar A, Malhotra P, Gupta S, ludtke A, Safayhi H, Ammon HP. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med. 2001; 67: 391-395.
16. Gerhardt H, Seifert F, Buvari P, Vogelsang H, Repges R. Therapy of active Crohn disease with Boswellia serrata extract H-15. Z. Gastroenrol. 2001; 39: 11-17.
17. Pandey RS, Singh BK, Tripathi YB. Extract of gum resin of Boswellia serrata L. inhibits lipopolysaccaride induced nitric oxide production in rat macrophages along with hypolipidemic property. Indian J Exp Biol. 2005; 43: 509-516.
18. Sailer ER, Schweizer S, Boden SE, Ammon HPT, Safayhi H. Characterization of an acetyl-11-keto-β-boswellic acid and arachidonate binding regulatory site of 5-lipoxygenase using photoaffinity labeling. Eur. J. Biochem. 1998; 256: 364-368.
19. Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HPT. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J. Pharmacol. Exp. Ther. 1992; 261: 1143-1146.
20. Safayhi H, Sailer ER, Ammon HPT. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto- β-boswellic acid. Mol. Pharmacol. 1995; 47: 1212-1216.
21. Sharma S, Thawani V, Hingorani L, Shrivastava M, Bhate VR, Khiyani R. Pharmacokinetics study of 11-keto-β-boswellic acid. Phytomedicine 2004; 11: 255-260.
22. Kaunzinger A, Baumeister A, Cuda K, Haring N, Schug B, Blume HH, Raddatz K, Fischer G, Zsilaveez SM. Determination of 11-keto-β-boswellic acid in human plasma. J. Pharm. Biomed. Anal. 2002; 28: 729-739.
23. Shah SA, Rathod IS, Suhagia BN, Patel DA, Parmar VK, Shah BK, Vaishnavi VM. Estimation of boswellic acids from market formulations of Boswellia serrata extract and 11-keto-β-boswellic acid in human plasma by high-performance thin-layer chromatography. J. chromatogr., B: Anal. Technol. Biomed. Life Sci. 2007; 848: 232-238.
24. Krueger P, Daneshfar R, Eckert GP, Klein J, Volmer DA, Bahr U, Muller WE, Karas M, Zsilavecz MS, Tawab MA. Metabolism of boswellic acids invitro and invivo. Drug Metab. Dispos. 2008; 36: 1135-1142.
25. Winter CA, Risley EA, Nuss GW. Carrageenan induced edema in hind paw of rat as an assay for anti-inflammatory drugs. Proc. Soc. Biol. Med. 1962; 11: 502-507.
26. Van-Abbe NJ, Nicholas P, Boom E. Exaggerated exposure in topical irritancy and sensitization testing. J. Soc. Cosmet. Chem. 1975; 26: 173-187.